| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ascendis Pharma A/s (ASND) has 2 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. ASND is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 4.4K | $927.6K | +350 | |
| Dir | 900 | $191.2K | +500 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Smith Scott Thomas | EVP &Chief Financial Officer | Buy | 100 | $219.00 | $21,900.00 | +2.3% | |
| May 29, 2026 | Bienaime Jean Jacques68 | Director | Buy | 500 | $223.12 | $111,562.00 | +27.8% | |
| May 29, 2026 | Smith Scott Thomas | EVP &Chief Financial Officer | Buy | 250 | $223.32 | $55,830.00 | +6.2% |